| Pharmaceutical active ingredients: |
| Nalidixic AcidPhenazopyridine Hydrochloride |
| Available forms, composition and doses of Pirifur: |
| Tablets, Film-Coated; Oral; Nalidixic Acid 500 mg; Phenazopyridine Hydrochloride 50 mg |
| Pirifur medical category: |
| Human |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| G04BX06 - PhenazopyridineJ01MB02 - Nalidixic Acid |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Sanofi-Aventis |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Naxilan-Plus | Nalidixic Acid; Phenazopyridine | Rayere Farmaceuticos |
| Sedonotricel | Nalidixic Acid; Phenazopyridine | Hortel |
| Azogen | Nalidixic Acid; Phenazopyridine Hydrochloride | Degort's Chemical |
| Azo-Wintomylon | Nalidixic Acid; Phenazopyridine Hydrochloride | Sanofi-Aventis |
| Nalixone | Nalidixic Acid; Phenazopyridine Hydrochloride | Son's Laboratorios Quimica |
| Alcofene | Nalmefene | Unidentified Pharmaceutical Company |
| Arthene | Nalmefene | Unidentified Pharmaceutical Company |
| Cervene | Nalmefene | Unidentified Pharmaceutical Company |
| Cessal | Nalmefene | Unidentified Pharmaceutical Company |
| Incystene | Nalmefene | Unidentified Pharmaceutical Company |